+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Uterine Cancer Drugs Market Research Reports

From
From
From
Endometrial Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Endometrial Cancer Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Endometrial Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Endometrial Cancer Treatment - Global Strategic Business Report

  • Report
  • December 2024
  • 192 Pages
  • Global
From
From
Endometrial Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Endometrial Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Advanced Endometrial Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Endometrial Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Endometrial Cancer Market - Product Thumbnail Image

Endometrial Cancer Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Research Report on China's Anastrozole Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Anastrozole Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
From
From
JEMPERLI (dostarlimab) Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

JEMPERLI (dostarlimab) Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Endometrial Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Endometrial Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Cyclophosphamide Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cyclophosphamide Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Endometrial Cancer - Epidemiology Forecast to 2030 - Product Thumbnail Image

Endometrial Cancer - Epidemiology Forecast to 2030

  • Report
  • May 2021
  • 42 Pages
  • Global
From
Loading Indicator

Uterine Cancer Drugs are medications used to treat cancer of the uterus. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and reduce the risk of recurrence. Commonly used drugs include chemotherapy, hormone therapy, targeted therapy, and immunotherapy. Chemotherapy drugs are used to kill cancer cells, while hormone therapy drugs are used to block the hormones that can cause cancer cells to grow. Targeted therapy drugs are used to target specific cancer cells, while immunotherapy drugs are used to boost the body's immune system to fight cancer. Some of the major companies in the Uterine Cancer Drugs market include Pfizer, Merck, Novartis, AstraZeneca, and Eli Lilly. These companies are involved in the research, development, and production of drugs for the treatment of uterine cancer. Show Less Read more